home / lobbying / lobbying_activities

lobbying_activities: 1377290

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1377290 244a9b2c-d36a-4c29-81fd-f50629031cbe Q1 AMERICAN ASSOCIATION FOR JUSTICE 4733 AMERICAN ASSOCIATION FOR JUSTICE 2013 first_quarter CSP (Arbitration Fairness Act); not formally introduced as of 3-31-2013, to prohibit mandatory binding arbitration in consumer contracts.(Fairness in Nursing Home Arbitration Act); not formally introduced as of 3-31-13, relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts. General lobbying with regard to the enforceability of mandatory, pre-disdpute arbitration provisions in employment and consumer contracts, including financial consumer contracts. (Foreign Manufacturers Legal Accountability Act); not formally introduced as of 3-31-2013, to require foreign manufacturers of products imported into the United States to establish registered agents in the United States who are authorized to accept service of process against such manufacturers, and for other purposes. Gemeral lobbying with regard to the preemption of state causes of action involving medical device and drug manufacturers. H.R.982 (Furthering Asbestos Claim Transparency Act); to amend title 11 of the United States Code to require the public disclosure by trusts established under section 524(g) of such title, of quarterly reports that contain detailed information regarding the receipt and disposition of claims for injuries based on exposure to asbestos, and the filing of such reports with the Executive Office for United States Trustees. General lobbying with regard to the regulation of compounding pharmacies and preservation of state-based causes of action. General lobbying with regard to the ability of consumers and injured parties to bring class actions. General lobbying with regard to the ability of injured consumers to bring causes of action against manufacturers and sellers of defective products. (Location Privacy Protection Act of 2012) not formally introduced as of 3-31-2013; to address voluntary location tracking of electronic communications devices; specific interest in creation of enforcement actions and Grassley Amendment (failed in Committee) to require transparency for outside counsel retained by State Attorneys General. General lobbying with regard to alternative litigation funding. General lobbying with regard to notice pleading in civil actions. General lobbying with regard to limitations on the ability to bring class actions involving the securities industry. HOUSE OF REPRESENTATIVES,SENATE,White House Office   940000 0 0 2013-04-18T13:42:55.767000-04:00
Powered by Datasette · Queries took 186.112ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API